Torrey Pines Investment β Full Portfolio
13 tracked investments Β· listed companies and verified rows first
Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors.
BiotechHealthtechPhiladelphia, US
Martin Lehr(Founder)inJennifer Minai-Azary(Executive Officer)inAlex Levit(Executive Officer)Linda Beth West(Director)Richard Jay Berman(Director)Philip Kantoff(Director)in
Co-investorsNextech Invest
Brenig Therapeutics is a biotechnology company developing small-molecule therapies for Parkinson's disease and other neurodegenerative disorders, using AI-driven drug discovery.
AI & Machine LearningBiotechHealthtech
Megan McGill(Chief Executive Officer)inIain Dukes(Chief Business Officer / Chairman of the Board)inNikolay Savchuk(Chief Operating Officer)Tien Dam(Chief Medical Officer)in
Co-investorsNew Enterprise Associates (NEA)OrbiMedBGV
i2020 Accelerator (T123 LLC) is a drug discovery accelerator that de-risks early-stage science and advances drug discovery platforms toward lead and clinical candidate stage within roughly two years, working across therapeutic areas such as oncology, immunology, and infectious diseases.
BiotechDeep TechHealthtechSan Diego, US
Co-investorsBioGeneration VenturesOrbiMedBGV
19Labs builds GALE, a smart point-of-care platform that brings a full clinic experience to schools, rural communities, and pharmacies.
Digital HealthHealthtechMedical Devices
Ram Fish(Founder & CEO)inGerald Horel(Founder)in
Co-investorsTransPacific Venture Partners
Contract research organization specializing in CNS preclinical efficacy and neurotoxicity evaluations using its patented Enhanced Spine Profiling (ESP) technology.
Clinical-stage drug-device company developing pegloprastide (AVB-620) for real-time surgical margin detection in cancer surgery.
Co-investorsAlexandria
Chromis Therapeutics is a biotech company with board members experienced in pharmaceutical development, corporate development, and healthcare investments.
BiotechHealthtechMedical DevicesSan Diego, US
BoardNikolay Savchuk(Chairman of the Board)Ronald Demuth(Director of the Board)Jennifer Giottonini Cayer(Director of the Board)
Elpida provides automated regulatory compliance monitoring for healthcare brands' digital communications.
AI & Machine LearningHealthtechMarketing TechSaaS
Co-investorsfresh.fundSkolkovo Foundation
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREPβPP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases.
BiotechDeep Tech
Timo(Scientific Co-founder)inErik(Scientific Co-founder)inSimon(Chief Executive Officer)inSebastian(Chief Operating Officer)in
Co-investorsInnovestor
Biotechnology company enhancing vaccine performance with its HD-MAP high-density microarray skin-delivery platform, targeting infectious disease and oncology.
Co-investorsOneVenturesR&D Tax Incentive
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.